Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. [ + ]

The world’s first graphene single-electron pump provides the speed of electron flow needed to create a new standard for electrical current based on electron charge. [ + ]

Bioniche (ASX:BNC) has hired an adviser to help it negotiate a sale of its animal health division and has received two preliminary partnership offers for bladder cancer treatment Urocidin. [ + ]

PE firm Mercury Capital has acquired a 30% stake in incumbent Australian CRO Novotech, with the option to increase its holding to 50%. [ + ]

Scientists from UOW and UNSW have patented a new drug technology for combating antibiotic-resistant bacteria, developed by thinking like the enemy. [ + ]

This week, experts from around Australia and two international leaders in the field will meet to discuss stem cell science and just how close we are to delivering on the promise of this field. [ + ]

Having a neighbourly chat improves seed germination in plants. [ + ]

BioDiem (ASX:BDM) has said its antimicrobial candidate BDM-I is ready for preclinical trials against Pneumocystosis, a parasitic fungus that can cause pneumonia. [ + ]

A new centre dedicated to research on the interaction between the nervous system and the immune system has been established on the Gold Coast. [ + ]

Researchers have demonstrated that metamaterials can be used to specifically influence the propagation of heat. [ + ]

Researchers have created a new tool to detect flaws in lithium-ion batteries as they are being manufactured; a step towards reducing defects and inconsistencies in the thickness of electrodes that affect battery life and reliability. [ + ]

JoVE has published research that demonstrates how a biosensor can detect antibiotic resistance in bacteria. The technology is a preliminary step in identifying and fighting superbugs. [ + ]

Cellmid (ASX:CDY) will pay around $4m in cash and stock to acquire Advangen Japan and, with it, the hair growth technology platform behind Cellmid’s evolis line. [ + ]

A global team of researchers has identified the gene behind an Australian toddler’s paediatric brain disorder in a discovery that is paving the way for the diagnosis and treatment of other children with genetic diseases. [ + ]

Members of AusBiotech are invited to participate in a survey to gauge the impact of the 2011 increase in the Clinical Trial Indemnity Insurance Compliance Requirement. [ + ]